Chromosome 22 complements apoptosis in Fas-and TNF-resistant mutant UK110 cells

K Noguchi1, M Naito, M Oshimura

  • 1Laboratory of Biomedical Research, Institute of Molecular and Cellular Biosciences, University of Tokyo.

Oncogene
|July 4, 1996
PubMed

Insights

Chromosome 22 restores apoptosis sensitivity in resistant leukemia cells. This suggests a gene on chromosome 22 is crucial for Fas and tumor necrosis factor receptor (TNFR) signaling upstream of key proteases.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Immunology

Background:

  • Fas and p55 tumor necrosis factor receptor (TNFR) mediate apoptosis upon activation.
  • The precise signal transduction pathway for Fas and p55 TNFR-induced apoptosis remains unclear.
  • A recessive mutant cell line, UK110, derived from U937 leukemia cells, exhibits resistance to Fas and p55 TNFR-mediated apoptosis.

Purpose of the Study:

  • To elucidate the signal transduction mechanism of apoptosis via Fas and p55 TNFR.
  • To identify genetic factors involved in Fas and p55 TNFR-mediated apoptosis resistance.
  • To investigate the role of chromosome 22 in restoring apoptosis sensitivity.

Main Methods:

  • Cytogenetic analysis of the UK110 mutant cell line.
  • Microcell-fusion technique to introduce chromosome 22 into UK110 cells.
  • Assessment of apoptosis sensitivity following treatment with anti-Fas and anti-p55 TNFR antibodies.
  • Evaluation of interleukin-1 beta converting enzyme (ICE)-like protease processing.

Main Results:

  • Introduction of chromosome 22 specifically restored sensitivity to Fas- and TNF-mediated apoptosis in UK110 cells.
  • Chromosome 22 introduction complemented the processing of ICE-like proteases (CPP32/Yama/Apopain and ICH-1L) after antibody treatment.
  • These findings indicate a gene on chromosome 22 is involved upstream of ICE-like proteases in the apoptosis pathway.

Conclusions:

  • A gene located on human chromosome 22 plays a critical role in the Fas and p55 TNFR apoptotic signaling pathway.
  • This gene acts upstream of ICE-like proteases, influencing their activation.
  • Restoring chromosome 22 can overcome apoptosis resistance in certain leukemia cells, offering potential therapeutic insights.

Related Concept Videos

Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...